Neurologic complications of polycythemia and their impact on therapy
Journal Article
·
· Oncology (Williston Park, N.Y.); (USA)
OSTI ID:6427387
- MD Anderson Cancer Center, Houston, TX (USA)
Polycythemia vera, a clonal stem cell disorder, produces neurologic problems in 50-80% of patients. Some symptoms, such as headache and dizziness, are related to hyperviscosity, and respond immediately to reduction of cell counts. Others seem to result from an associated coagulopathy. Patients with polycythemia tend to develop both arterial and venous thrombosis and are prone to hemorrhages. Treatments for polycythemia include phlebotomy, chlorambucil supplemented with phlebotomy, and {sup 32}P plus phlebotomy. Whatever treatment is chosen, the aim of therapy should be to reduce the hematocrit to approximately 40-45%.37 references.
- OSTI ID:
- 6427387
- Journal Information:
- Oncology (Williston Park, N.Y.); (USA), Journal Name: Oncology (Williston Park, N.Y.); (USA) Vol. 4:3; ISSN 0890-9091; ISSN OCLGE
- Country of Publication:
- United States
- Language:
- English
Similar Records
Multiple myeloma on polycythemia vera following radioactive phosphorus therapy
INCREASED BLOOD VOLUME IN POLYCYTHEMIA VERA AND THE EFFECT ON IT OF TREATMENT WITH P$sup 3$$sup 2$
Association between systemically administered radioisotopes and subsequent malignant disease
Journal Article
·
Sun Oct 31 23:00:00 EST 1976
· South. Med. J.; (United States)
·
OSTI ID:7219757
INCREASED BLOOD VOLUME IN POLYCYTHEMIA VERA AND THE EFFECT ON IT OF TREATMENT WITH P$sup 3$$sup 2$
Journal Article
·
Sat Dec 31 23:00:00 EST 1960
· Z. ges. inn. Med. u. ihre Grenzgebiete
·
OSTI ID:4829345
Association between systemically administered radioisotopes and subsequent malignant disease
Conference
·
Sat Jan 31 23:00:00 EST 1976
· Cancer, Suppl., v. 37, no. 2, pp. 1097-1101
·
OSTI ID:4031372
Related Subjects
550600 -- Medicine
550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
AMINES
ANIMAL CELLS
ANTINEOPLASTIC DRUGS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BLOOD COUNT
CARBOXYLIC ACIDS
CARDIOVASCULAR DISEASES
CHLORAMBUCIL
COMBINED THERAPY
DAYS LIVING RADIOISOTOPES
DISEASES
DOCUMENT TYPES
DRUGS
ISOTOPES
LIGHT NUCLEI
MEDICINE
MONOCARBOXYLIC ACIDS
NERVOUS SYSTEM DISEASES
NUCLEI
ODD-ODD NUCLEI
ORGANIC ACIDS
ORGANIC CHLORINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
PATIENTS
PHOSPHORUS 32
PHOSPHORUS ISOTOPES
RADIOISOTOPES
REVIEWS
SOMATIC CELLS
STEM CELLS
SURGERY
SYMPTOMS
THERAPY
THROMBOSIS
VASCULAR DISEASES
550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
AMINES
ANIMAL CELLS
ANTINEOPLASTIC DRUGS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BLOOD COUNT
CARBOXYLIC ACIDS
CARDIOVASCULAR DISEASES
CHLORAMBUCIL
COMBINED THERAPY
DAYS LIVING RADIOISOTOPES
DISEASES
DOCUMENT TYPES
DRUGS
ISOTOPES
LIGHT NUCLEI
MEDICINE
MONOCARBOXYLIC ACIDS
NERVOUS SYSTEM DISEASES
NUCLEI
ODD-ODD NUCLEI
ORGANIC ACIDS
ORGANIC CHLORINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
PATIENTS
PHOSPHORUS 32
PHOSPHORUS ISOTOPES
RADIOISOTOPES
REVIEWS
SOMATIC CELLS
STEM CELLS
SURGERY
SYMPTOMS
THERAPY
THROMBOSIS
VASCULAR DISEASES